期刊文献+

可卡因及HIV感染与亚临床心脏动脉粥样硬化疾病

下载PDF
导出
摘要 H IV感染和滥用可卡因是当前社会严重的公共卫生问题。虽然在二者人群中常可见到心脏疾病临床表现,但H IV感染、滥用可卡因及二者结合时对心脏动脉粥样硬化亚临床状态如血小板反应性和活性状态、血清C反应蛋白活性、内皮细胞功能及冠状动脉钙化指数的影响有待进一步研究。
出处 《心脏杂志》 CAS 2006年第4期462-464,共3页 Chinese Heart Journal
  • 相关文献

参考文献10

  • 1UNAIDS/WHO. UNAIDS/WHO 2004 Report on the global AIDS epidemic[ R ]. AIDS epidemic update, December 2004, ⅩⅤ international AIDS conference Bangkok, July 11 - 16.
  • 2The Henry J. Kaiser family foundation. A local view of the HIV/ AIDS epidemic in the united states: Assessing the impact of HIV/ AIDS in metropolitan statistical areas[ R]. March 2004.
  • 3Vocci FJ, Acri J, Elkashef A. Medication development for addictive disorders: the state of the science[J]. Am J Psychiatry,2005, 162 (8) : 1432 -1440.
  • 4Meng QY, Lima JA, Lai H, et al. Elevated C-reactive protein levels are associated with endothelial dysfunction in chronic cocaine users [J]. lnt J Cardiol,2003, 88(2 -3) :191 -198.
  • 5张美芳,何巍,俞锋,楼福庆.C-反应蛋白和冠心病相关分析[J].心脏杂志,2003,15(1):19-19. 被引量:2
  • 6徐彤彤,于方.冠心病患者血清C反应蛋白水平的变化及其临床意义[J].心脏杂志,2004,16(5):443-445. 被引量:7
  • 7罗明,俞文萍,王宏保.辛伐他汀联合依那普利干预对急性冠脉综合征患者血清C反应蛋白和白介素-6的影响[J].心脏杂志,2005,17(2):137-139. 被引量:6
  • 8Meng QY, Joao AC, Lima MD, et al. Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors [ J ]. Am Heart J, 2002 , 144 (4) :642 -648.
  • 9Lai S, Lima JA, Lai H, et al. Human immunodeficiency virus 1 infection, cocaine, and coronary calcification [ J ]. Arch Intern Med, 2005 ,165(6) :690 -695.
  • 10Lai S, Lai H, Meng Q, et al. Effect of cocaine use on coronary calcium among black adults in Baltimore, Maryland[J]. Am J Cardiol,2002,90( 3 ) :326 - 328.

二级参考文献13

  • 1Ridker PM, Stampfer MJ , Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease [J]. JAMA, 200
  • 2Blake PM, Rifai N, Clearfield M, et al. Measurement of C-reactive protein and other inflammatory risk markers in acute coronary syndromes[J]. J Am Coll Cardiol, 2003, 41:37-42.
  • 3Ridker PM, Rifai N, Clearfield M, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events[J]. N Engl J Med, 2001, 344: 1959-1965.
  • 4Maseri A. Inflammation, atherosclerosis, and ischemic events - exploring the hidden side of the moon[J]. N Engl J Med, 1977,336:1014 -1016.
  • 5Ross R. Atherosclerosis -an inflammatory disease[J]. N Engl J Med,1999,340(2) :115 - 126.
  • 6Gaspardone A, Crea F, Versaci F, et al. Predictive value of C-resctive protein after successful coronaryartery stenting in patients with stable angina[J]. Am J Cardiol,1998 ,82 :515 -518.
  • 7Yudkin JS, Kumari M, Humphries SE, et al. Inflammation, obesity,stress and coronary heart disease: is interleukin-6 the link? [J].Atherosc lerosis,2000,148 (2) :209-214.
  • 8Oltrona L, Ardissino D, Merlini PA, et al. C-reactive protein elevation and early outcome in patients with unstable angina pectoris[J].Am J Cardiol,1997,80:1002 -1004.
  • 9赵季红,张利华,薛玉生,周秀荣,那桂平.冠心病C反应蛋白及甘油三酯/高密度脂蛋白胆固醇比值变化的研究[J].心脏杂志,2001,13(2):130-132. 被引量:18
  • 10张利华,赵季红,薛玉生,刘峰.C反应蛋白与冠心病病变程度相关的研究[J].心脏杂志,2002,14(1):25-26. 被引量:35

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部